Search Results - "Bilensoy, E."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2
  3. 3

    Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles by Cirpanli, Y, Yerlikaya, F, Ozturk, K, Erdogar, N, Launay, M, Gegu, C, Leturgez, T, Bilensoy, E, Calis, S, Capan, Y

    Published in Pharmazie (01-12-2010)
    “…Tamoxifen (TAM), the clinical choice for the antiestrogen treatment of advanced or metastatic breast cancer, was formulated in nanoparticulate carrier systems…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Transcription efficiency of tamoxifen citrate-loaded β-cyclodextrin nanoparticles by Vural, I., Memisoglu-Bilensoy, E., Renoir, J.M., Bochot, A., Duchêne, D., Hincal, A.A.

    “…Nanoparticles of β-CDC6 were prepared according to the nanoprecipitation technique. Blank and tamoxifen citrate loaded nanoparticles were characterized by…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model by Çırpanlı, Yasemin, Allard, Emilie, Passirani, Catherine, Bilensoy, Erem, Lemaire, Laurent, Çalış, Sema, Benoit, Jean-Pierre

    Published in International journal of pharmaceutics (17-01-2011)
    “…In this study, camptothecin loaded nanoparticulate delivery systems were developed with either amphiphilic cyclodextrins, poly(lactide-co-glycolide) or…”
    Get full text
    Journal Article
  8. 8

    Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving by Memisoglu-Bilensoy, Erem, Hincal, A. Atilla

    Published in International journal of pharmaceutics (27-03-2006)
    “…Sterility is required as stated by compendial requirements and registration authorities worldwide for an injectable drug carrier system. In this study,…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12